LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

22/03/2021
PRESS RELEASE

EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe

The National Associations Council of EuropaBio is pleased to launch its 2021 Summit ‘Building on Biotechnology: From vaccines to economic Growth for Europe’ being hosted on May 10.

This inaugural Summit for the National Associations Council (NAC) will address how national priorities and synergies should be used to create an economic recovery pathway for Europe through biotechnology.

The Covid crisis has created many precedents for the faster delivery of biotechnologies to market, and Europe now has a significant opportunity to continue this momentum across all sectors and ensure a competitive global position. Initiatives such as the European Health Emergency Preparedness and Response Authority (HERA), plus the Industrial and Circular Economy Strategies are all enablers for biotechnology and will be addressed in the Summit.

The NAC Summit, jointly hosted with Portugal’s P-BIO in line with the current European Council Presidency, addresses its mission in two key sessions:

Innovation and delivery for vaccine across countries and value chains Large companies SMEs and universities active in vaccine development will present how they were able to bring the vaccines to patient in unprecedented speed. They will share the enabling factors behind their collaboration and development, including partnering, finance, policy and regulation.

Vaccine learning – Driving economic delivery with biotechnology SME presentations will demonstrate potential for the future, followed by a panel discussion with National Associations where priorities will be agreed for effective and impactful mobilisation of national resources to achieve a competitive Europe.

The Summit will develop and publish a position for EuropaBio’s National Associations and use this as a roadmap in the Council’s work in supporting European development through national actions and synergies.

Dr Claire Skentelbery, Director General of EuropaBio commented “Europe has a powerful engine to build competitiveness, through its Member and partner countries on the continent. This Summit reflects priorities and capabilities of countries of all sizes in Europe and helps to ensure that we all progress together”.

Filipa Sacadura, Secretary General of P-BIO added “Portugal’s biotech sector is actively involved in vaccine development within global partnerships and this Summit reflects our own national priorities to further build on the economic power of biotechnology in the future”.

REGISTER NOW!

REGISTER HERE


REGISTER HERE

EuropaBio and P-BIO launch the National Associations Council Summit 2021


Download
2021_04_N_PR_EuropaBio-P-BIO-Launch-NAC-SummitDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
10/04/2025

EU biotechnology competitiveness for the future; high level dialogue with EVP Séjourné


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.